224 related articles for article (PubMed ID: 23455991)
1. Disease state fingerprint in frontotemporal degeneration with reference to Alzheimer's disease and mild cognitive impairment.
Muñoz-Ruiz MÁ; Hartikainen P; Hall A; Mattila J; Koikkalainen J; Herukka SK; Julkunen V; Vanninen R; Liu Y; Lötjönen J; Soininen H
J Alzheimers Dis; 2013; 35(4):727-39. PubMed ID: 23455991
[TBL] [Abstract][Full Text] [Related]
2. Cortical thickness in frontotemporal dementia, mild cognitive impairment, and Alzheimer's disease.
Hartikainen P; Räsänen J; Julkunen V; Niskanen E; Hallikainen M; Kivipelto M; Vanninen R; Remes AM; Soininen H
J Alzheimers Dis; 2012; 30(4):857-74. PubMed ID: 22466003
[TBL] [Abstract][Full Text] [Related]
3. Integrating Biomarkers for Underlying Alzheimer's Disease in Mild Cognitive Impairment in Daily Practice: Comparison of a Clinical Decision Support System with Individual Biomarkers.
Rhodius-Meester HF; Koikkalainen J; Mattila J; Teunissen CE; Barkhof F; Lemstra AW; Scheltens P; Lötjönen J; van der Flier WM
J Alzheimers Dis; 2016; 50(1):261-70. PubMed ID: 26577521
[TBL] [Abstract][Full Text] [Related]
4. Comparisons of clinical symptoms in biomarker-confirmed Alzheimer's disease, dementia with Lewy bodies, and frontotemporal dementia patients in a local memory clinic.
Shea YF; Ha J; Chu LW
Psychogeriatrics; 2015 Dec; 15(4):235-41. PubMed ID: 25533477
[TBL] [Abstract][Full Text] [Related]
5. Generalizability of the disease state index prediction model for identifying patients progressing from mild cognitive impairment to Alzheimer's disease.
Hall A; Muñoz-Ruiz M; Mattila J; Koikkalainen J; Tsolaki M; Mecocci P; Kloszewska I; Vellas B; Lovestone S; Visser PJ; Lötjonen J; Soininen H; ; ;
J Alzheimers Dis; 2015; 44(1):79-92. PubMed ID: 25201784
[TBL] [Abstract][Full Text] [Related]
6. Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e.
Susanto TA; Pua EP; Zhou J;
J Alzheimers Dis; 2015; 45(1):253-68. PubMed ID: 25524955
[TBL] [Abstract][Full Text] [Related]
7. Optical Coherence Tomography Reveals Retinal Neuroaxonal Thinning in Frontotemporal Dementia as in Alzheimer's Disease.
Ferrari L; Huang SC; Magnani G; Ambrosi A; Comi G; Leocani L
J Alzheimers Dis; 2017; 56(3):1101-1107. PubMed ID: 28106555
[TBL] [Abstract][Full Text] [Related]
8. Relation between subcortical grey matter atrophy and conversion from mild cognitive impairment to Alzheimer's disease.
Yi HA; Möller C; Dieleman N; Bouwman FH; Barkhof F; Scheltens P; van der Flier WM; Vrenken H
J Neurol Neurosurg Psychiatry; 2016 Apr; 87(4):425-32. PubMed ID: 25904810
[TBL] [Abstract][Full Text] [Related]
9. The National Institute on Aging-Alzheimer's Association research criteria for mild cognitive impairment due to Alzheimer's disease: predicting the outcome.
Guo LH; Alexopoulos P; Eisele T; Wagenpfeil S; Kurz A; Perneczky R
Eur Arch Psychiatry Clin Neurosci; 2013 Jun; 263(4):325-33. PubMed ID: 22932720
[TBL] [Abstract][Full Text] [Related]
10. Single-domain amnestic mild cognitive impairment identified by cluster analysis predicts Alzheimer's disease in the european prospective DESCRIPA study.
Damian M; Hausner L; Jekel K; Richter M; Froelich L; Almkvist O; Boada M; Bullock R; De Deyn PP; Frisoni GB; Hampel H; Jones RW; Kehoe P; Lenoir H; Minthon L; Olde Rikkert MG; Rodriguez G; Scheltens P; Soininen H; Spiru L; Touchon J; Tsolaki M; Vellas B; Verhey FR; Winblad B; Wahlund LO; Wilcock G; Visser PJ
Dement Geriatr Cogn Disord; 2013; 36(1-2):1-19. PubMed ID: 23651945
[TBL] [Abstract][Full Text] [Related]
11. Comparing predictors of conversion to Alzheimer's disease using the disease state index.
Muñoz-Ruiz MÁ; Hall A; Mattila J; Koikkalainen J; Herukka SK; Vanninen R; Liu Y; Lötjönen J; Soininen H;
Neurodegener Dis; 2014; 13(2-3):200-2. PubMed ID: 23969422
[TBL] [Abstract][Full Text] [Related]
12. The Tree-Drawing Test (Koch's Baum Test): A Useful Aid to Diagnose Cognitive Impairment.
Stanzani Maserati M; Matacena C; Sambati L; Oppi F; Poda R; De Matteis M; Gallassi R
Behav Neurol; 2015; 2015():534681. PubMed ID: 26175548
[TBL] [Abstract][Full Text] [Related]
13. Varying strength of cognitive markers and biomarkers to predict conversion and cognitive decline in an early-stage-enriched mild cognitive impairment sample.
Egli SC; Hirni DI; Taylor KI; Berres M; Regeniter A; Gass A; Monsch AU; Sollberger M
J Alzheimers Dis; 2015; 44(2):625-33. PubMed ID: 25322924
[TBL] [Abstract][Full Text] [Related]
14. Correlations between cerebellar and brain volumes, cognitive impairments, ApoE levels, and APOE genotypes in patients with AD and MCI.
Łojkowska W; Witkowski G; Bednarska-Makaruk M; Wehr H; Sienkiewicz-Jarosz H; Graban A; Bochyńska A; Wiśniewska A; Gugała M; Sławińska K; Sawicka B; Poniatowska R; Ryglewicz D
Curr Alzheimer Res; 2013 Nov; 10(9):964-72. PubMed ID: 24117117
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of biomarkers in the diagnosis and prognosis of early-onset cognitive impairment.
Balasa M; Sánchez-Valle R; Antonell A; Bosch B; Olives J; Rami L; Castellví M; Molinuevo JL; Lladó A
J Alzheimers Dis; 2014; 40(4):919-27. PubMed ID: 24577466
[TBL] [Abstract][Full Text] [Related]
16. More atrophy of deep gray matter structures in frontotemporal dementia compared to Alzheimer's disease.
Möller C; Dieleman N; van der Flier WM; Versteeg A; Pijnenburg Y; Scheltens P; Barkhof F; Vrenken H
J Alzheimers Dis; 2015; 44(2):635-47. PubMed ID: 25322925
[TBL] [Abstract][Full Text] [Related]
17. White matter hyperintensities are associated with grey matter atrophy and cognitive decline in Alzheimer's disease and frontotemporal dementia.
Dadar M; Manera AL; Ducharme S; Collins DL
Neurobiol Aging; 2022 Mar; 111():54-63. PubMed ID: 34968832
[TBL] [Abstract][Full Text] [Related]
18. Different regional patterns of cortical thinning in Alzheimer's disease and frontotemporal dementia.
Du AT; Schuff N; Kramer JH; Rosen HJ; Gorno-Tempini ML; Rankin K; Miller BL; Weiner MW
Brain; 2007 Apr; 130(Pt 4):1159-66. PubMed ID: 17353226
[TBL] [Abstract][Full Text] [Related]
19. Cognitive and neuroimaging profiles in mild cognitive impairment and Alzheimer's disease: data from the Spanish Multicenter Normative Studies (NEURONORMA Project).
Sánchez-Benavides G; Peña-Casanova J; Casals-Coll M; Gramunt N; Molinuevo JL; Gómez-Ansón B; Aguilar M; Robles A; Antúnez C; Martínez-Parra C; Frank-García A; Fernández-Martínez M; Blesa R;
J Alzheimers Dis; 2014; 41(3):887-901. PubMed ID: 24718100
[TBL] [Abstract][Full Text] [Related]
20. Progranulin and Amyloid-β Levels: Relationship to Neuropsychology in Frontotemporal and Alzheimer's Disease.
Körtvélyessy P; Gukasjan A; Sweeney-Reed CM; Heinze HJ; Thurner L; Bittner DM
J Alzheimers Dis; 2015; 46(2):375-80. PubMed ID: 25777512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
